DDIT3 and amelogenesis imperfecta type 1G: have shown that inhibiting the ATF4/CHOP pathway in rat models of diabetic myocardial infarction could not ameliorate the ferroptosis, while a ferroptosis inhibitor could reduce the occurrence of ERS, oxidative stress, and cardiomyocyte injury (Li, Li, et al., 2020).